Additionally, murine data demonstrate that, albeit with small sample sizes, have confirmed that glycated hemoglobin (HbA1c) levels and insulin dosages in T2DM patients can decrease significantly within a short time frame (12–24 weeks) following HUCMSCs transplantation [17]. The gene discussed is INS; the disease is type 2 diabetes mellitus.